{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:08:44Z","timestamp":1771416524211,"version":"3.50.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:p>Paraneoplastic pemphigus (PNP) is a rare autoimmune blistering disorder that is often resistant to conventional immunosuppressive therapies. We report a case of refractory PNP associated with follicular dendritic cell sarcoma, in which functional T-cell analysis revealed a dominant T helper 1\/T cytotoxic1 (Th1\/Tc1) immune response and elevated serum tumour necrosis factor (TNF), guiding successful treatment with the TNF inhibitor etanercept. This case underscores the potential of molecular-guided therapy targeting cellular immunity in managing refractory PNP.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf462","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:01:58Z","timestamp":1763125318000},"page":"589-590","source":"Crossref","is-referenced-by-count":0,"title":["Molecular-guided targeted therapy with tumour necrosis factor inhibitor for the treatment of refractory paraneoplastic pemphigus"],"prefix":"10.1093","volume":"194","author":[{"given":"Hsin-Yu","family":"Shih","sequence":"first","affiliation":[{"name":"Department of Dermatology, Chang Gung Memorial Hospital , Linkou, Taoyuan ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-0959","authenticated-orcid":false,"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chang Gung Memorial Hospital , Linkou, Taoyuan ,","place":["Taiwan"]},{"name":"Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital , Linkou, Taoyuan ,","place":["Taiwan"]},{"name":"College of Medicine, Chang Gung University , Taoyuan ,","place":["Taiwan"]},{"name":"Department of Dermatology, Xiamen Chang Gung Hospital , Xiamen ,","place":["China"]},{"name":"School of Medicine, National Tsing Hua University , Hsinchu ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-4235","authenticated-orcid":false,"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chang Gung Memorial Hospital , Linkou, Taoyuan ,","place":["Taiwan"]},{"name":"Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital , Linkou, Taoyuan ,","place":["Taiwan"]},{"name":"College of Medicine, Chang Gung University , Taoyuan ,","place":["Taiwan"]},{"name":"Department of Dermatology, Xiamen Chang Gung Hospital , Xiamen ,","place":["China"]},{"name":"School of Medicine, National Tsing Hua University , Hsinchu ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"2026021806310546000_ljaf462-B1","volume-title":"Paraneoplastic pemphigus","author":"Kappius","year":"2025"},{"key":"2026021806310546000_ljaf462-B2","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms18122532","article-title":"paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy","volume":"18","author":"Paolino","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026021806310546000_ljaf462-B3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaad.2023.08.084","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part II. Diagnosis and management","volume":"91","author":"Huang","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026021806310546000_ljaf462-B4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026021806310546000_ljaf462-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026021806310546000_ljaf462-B6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.imbio.2011.07.006","article-title":"Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-\u03b3-producing NK cell and regulatory T cell subsets","volume":"216","author":"Aravena","year":"2011","journal-title":"Immunobiology"},{"key":"2026021806310546000_ljaf462-B7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf462\/65295918\/ljaf462.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/589\/65295918\/ljaf462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/589\/65295918\/ljaf462.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:31:13Z","timestamp":1771414273000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/3\/589\/8323807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":7,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,15]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf462","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,15]]}}}